A retrospective analysis of Terlipressin infusion in patients with refractory hypotension after cardiac surgery

Journal of Cardiovascular Surgery

Volumn 49, Issue 3, 2008, Pages 381-387

  Kunstyr, Jan ^a,d   Lincova, D ^b   Mourad, M ^c   Lips, M ^a   Cermak, T ^a   Kotulak, T ^a   Blaha, J ^a   Rubes, D ^a   Matias, M ^a   Stritesky, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c DR SOLIMAN FAKEEH HOSPITAL   (Saudi Arabia)

^d NONE   (Czech Republic)

Author keywords

Cardiac surgical procedures; Extracorporeal circulation; Terlipressin; Vasodilatation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INOTROPIC AGENT; LACTIC ACID; NORADRENALIN; TERLIPRESSIN;

ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTINUOUS RENAL REPLACEMENT THERAPY; CREATINE KINASE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TREATMENT FAILURE; EXTRACORPOREAL CIRCULATION; FEMALE; FLUID THERAPY; HEART INFARCTION; HEART RATE; HEART STROKE VOLUME; HEART SURGERY; HUMAN; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SEPSIS;

AGED; ANALYSIS OF VARIANCE; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPOTENSION; INFUSIONS, INTRAVENOUS; LYSINE VASOPRESSIN; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVORS; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 46749130469     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Landry DW, Oliver JAO. The pathogenesis of vasodilatory shock. N Engl J Med 2001;345:588-95.
2. Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg1998;116:973-80.
3. Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with Norepinephrine therapy. Crit Care Med 1988;16:663-6.
4. Groeneveld ABJ, Nauta JJP, Thijs LG. Peripheral vascular resistance in septic shock: its relation to outcome. Intensive Care Med 1988;14:141-7.
5. Dunser MW, Mayr AJ, Ulmer H, Fritsch N, Knotzer H, Pajk W et al. The effects of Vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001;93:7-13.
6. Holmes CL, Patel BM, Russel JA, Walley KR. Physiology of Vasopressin relevant to management of septic shock. Chest 2001;120:989-1002.
7. Eyraud D, Brabant S, Dieudonne N, Fleron MH, Gilles G, Bertrand M et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anest Analg 1999;88:980-4.
8. Medel J, Boccara G, V de Steen E, Bertrand M, Godet G, Coriat P. Terlipressin for treating intraoperative hypotension: can it unmask myocardial ischemia? Anesth Analg 2001;93:53-5.
9. Kam PCA, Williams S, Yoong FFY. Vasopressin and Terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004;59:993-1001.
10. O'Brien A, Clapp L, Singer M. Terlipressin for Norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.
11. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Review: Cochrane Database Syst Rev 2003;CD002147.
12. Nilsson G, Lindblom P, Ohlin, Berling R, Vermesson E. Pharmacoknetics of Terlipressin after single i.v. doses to healthy volunteers. Drug Exp Clin Res 1990;16:307-14.
13. Leather HA, Segers P, Berends N, Vandermeersch E, Wouters PF. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002;30:2548-52.
14. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W et al. Arginine Vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 2003;107:2313-9.
15. Morelli A, Rocco M, Conti G, Orechhioni A, De Gaetano A, Cortese G et al. Effects of Terlipressin on systemic and regional hemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med 2004;30:597-604.
16. Scharte M, Meyer J, Van Aken H, Bone HG. Hemodynamic effects of Terlipressin (a synthetic analog of Vasopressin) in healthy and endotoxemic sheep. Crit Care Med 2001;29:1756-60.
17. Bernadich C, Bandi JC, Melin P, Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with Terlipressin and Vasopressin on systemic hemodynamics in a rat model of portal hypertension. Hepatology 1998;27:351-6.
18. Westphal M, Stubbe H, Sielenkamper AW, Borgulya R, Van Aken H, Ball C et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport. Intensive Care Med 2003;29:301-8.
19. Westphal M, Freise H, Kehrel BE, Bone HG, Van Aken H, Sielenkamper AW. Arginine Vasopressin compromises gut mucosal microcirculation in septic rats. Crit Care Med 2004;32:194-200.
20. Van Haren FM, Rozendaal FW, van der Hoeven JG. The effect of Vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 2003;124:2256-60.